2021
DOI: 10.3390/metabo11010051
|View full text |Cite
|
Sign up to set email alerts
|

L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine

Abstract: Biomarker discovery and implementation are at the forefront of the precision medicine movement. Modern advances in the field of metabolomics afford the opportunity to readily identify new metabolite biomarkers across a wide array of disciplines. Many of the metabolites are derived from or directly reflective of mitochondrial metabolism. L-carnitine and acylcarnitines are established mitochondrial biomarkers used to screen neonates for a series of genetic disorders affecting fatty acid oxidation, known as the i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
143
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 178 publications
(180 citation statements)
references
References 135 publications
(210 reference statements)
7
143
2
Order By: Relevance
“…Since circulating C16:1 9cis has been shown to be proportional to FM [ 48 ], the negative correlation between CRF and C16:1 9cis might be explained by the generally lower FM (%) in fitter females. Acylcarnitines are intermediates in the transport of LCFAs to mitochondria or byproducts of β-oxidation [ 49 ]. Although blood acylcarnitines have been identified as markers of insulin resistance, mitochondrial overload, and incomplete fat oxidation [ 50 ], they are also physiologically elevated in conditions with high lipolytic rates [ 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…Since circulating C16:1 9cis has been shown to be proportional to FM [ 48 ], the negative correlation between CRF and C16:1 9cis might be explained by the generally lower FM (%) in fitter females. Acylcarnitines are intermediates in the transport of LCFAs to mitochondria or byproducts of β-oxidation [ 49 ]. Although blood acylcarnitines have been identified as markers of insulin resistance, mitochondrial overload, and incomplete fat oxidation [ 50 ], they are also physiologically elevated in conditions with high lipolytic rates [ 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…Long-chain acylcarnitines, the transport form of cytosolic long-chain FAs into mitochondria, play critical roles in cardiac metabolism and the supply of energy since they are the predominant source of ATP production in cardiac mitochondria via β-oxidation [31]. Recently, LCACs were described as blood-circulating biomarkers associated with cardiovascular diseases [39][40][41]. However, whether LCACs directly affect myocardial function, and particularly whether this effect is positively or negatively inotropic, is undecided [42].…”
Section: Discussionmentioning
confidence: 99%
“…One reason for this could be ~2-fold decrease in free fatty acid content in KO pancreatic mitochondria (Figure 7J), likely a consequence of reduced availability of lipid droplets (Figures S2, S3) that deliver free fatty acids to mitochondria (51). With LC-MS/GC-MS, we also showed increased levels of long-chain acylcarnitines in KO pancreas (Figure 7K), an indication of impaired β-oxidation (52,53).…”
Section: Gnptab Ablation Causes Mitochondrial Dysfunction In Pancreasmentioning
confidence: 87%